medibles | CBD Personalized

Bobby Ntoya

Game Changer? Exploring the Role of Cannabinoid Therapy in Sports Performance and Recovery

As public attitudes shift and sports leagues revisit cannabis policy, a powerful question is emerging across locker rooms, training facilities, and research labs alike: Can cannabinoids like CBD and THC help athletes train smarter, recover faster, and stay healthier? A new peer-reviewed paper titled “Cannabinoid Therapy in Athletics” (Thompson et al., 2024) suggests the answer […]

Game Changer? Exploring the Role of Cannabinoid Therapy in Sports Performance and Recovery Read More »

medibles, a BIOMED company, Partners with the NIH All of Us Research Program to advance the Future of Personalized and Precision Medicine

At medibles, we believe the future of medicine is precise and personalized. Today, we’re excited to share a significant step forward in that vision. Medibles, the personalized health and wellness platform developed by BIOMED Inc., is proud to announce our participation in the National Institutes of Health’s (NIH) All of Us Research Program. This partnership

medibles, a BIOMED company, Partners with the NIH All of Us Research Program to advance the Future of Personalized and Precision Medicine Read More »

CBD Drug Interaction Databaset

medibles™ Expands its CBD-Drug Interaction Database, Cross-Examining More Than 5,400 Prescription Medications

Certain drugs interact with Cannabidiol; these interactions typically involve drugs metabolized by CYP450 enzymes and could possibly interact with CBD. LOS ANGELES, April 11, 2025 /PRNewswire/ — As the wellness industry evolves, more people are turning to Cannabidiol (CBD) for relief, recovery, and resilience. But as with any active compound, CBD does not exist in

medibles™ Expands its CBD-Drug Interaction Database, Cross-Examining More Than 5,400 Prescription Medications Read More »

BIOMED, Chosen As A Top Ten Finalists For The MedTech Color 2023 Pitch Competition

Today, Los Angeles, February 10, 2023 /PRNewswire/ — BIOMED, medibles parent company and the leading next-generation healthcare platform, was chosen as one of the top ten finalists for the MedTech Color 2023 Pitch Competition. MedTech Color (MTC) is a nonprofit organization that aims to advance the representation of persons of color in the Medtech industry.

BIOMED, Chosen As A Top Ten Finalists For The MedTech Color 2023 Pitch Competition Read More »

Federal Reserve Bank states Cannabis Industry Has Boosted Economic Activity in Several States

Cannabis legalization has been an enormous success with a significant economic impact. The new report from this Federal Reserve Bank district shows how cannabis-related businesses create jobs and generate tax revenue. An analysis was published last week by the Federal Reserve bank of Kansas City, which covers the 10th District of the Federal Reserve, which includes

Federal Reserve Bank states Cannabis Industry Has Boosted Economic Activity in Several States Read More »

Does CBD Help Relieve Stress and Social Anxiety Disorder?

Cannabidiol (CBD) is a drug being studied for its ability to treat many psychiatric disorders. The current review looked at whether CBD could be used to treat anxiety-related disorders by assessing evidence from preclinical, human experimental, clinical, and epidemiological studies. The review found strong evidence that CBD can be used to treat panic disorder, social anxiety

Does CBD Help Relieve Stress and Social Anxiety Disorder? Read More »

New Study, Pharmaceutical Companies Losing Billions After States Legalize Cannabis

The legalization of cannabis has had a significant effect on pharmaceutical companies. A new study research project titled “U.S. Cannabis Laws Projected to Cost Generic, and Brand Pharmaceutical Firms Billions” used CRSP US Stock North America Daily Update, a third-party dataset; found that, since 1996, when legalizations began in U.S states for both generic and brand-name drugs alike,

New Study, Pharmaceutical Companies Losing Billions After States Legalize Cannabis Read More »

New Research: Neuroimaging research shows the potential of CBD’s protective properties

The data from two placebo-controlled, double-blind studies suggest that CBD seems to buffer against some acute effects on the brain with THC. According to study outcomes published in the Journal of Psychopharmacology, more significant strains containing more CBD may be less harmful. “One of the most interesting things we found was that some cannabinoids work better

New Research: Neuroimaging research shows the potential of CBD’s protective properties Read More »

You’re unique. Your CBD regimen should be too.

medibles™ Expands Proprietary Algorithm and Questionnaire Tailored to Each Unique Customer

Today, Los Angeles, May 13, 2022 /PRNewswire/ — medibles, the leading next-generation subscription-based platform, announced it had enhanced its proprietary algorithm and online health questionnaire. medibles’ algorithm is based on thousands of research studies and the expertise of the company’s Medical Advisory Board. As a result, the individualized assessments meet consumers’ desires to find the correct CBD dosage

medibles™ Expands Proprietary Algorithm and Questionnaire Tailored to Each Unique Customer Read More »